Brain-derived neurotrophic factor (BDNF) induces synaptic potentiation at both neuromuscular junctions (NMJs
Introduction
Brain-derived neurotrophic factor (BDNF) plays important roles during neuronal development, including modulation of cell survival, neuronal differentiation, axonal guidance, dendritic outgrowth, spine formation, and synaptic plasticity (Schinder and Poo, 2000) . BDNF expression is dynamically regulated by physiological and pathological stimuli, and changes in BDNF expression are associated with many mental disorders, presumably through dysregulation of synapses (Lu et al., 2008; Ma et al., 2009; Castrén and Rantamäki, 2010) . BDNF potently modulates synaptogenesis, synaptic transmission, and plasticity during early development and in the adult brain (Poo, 2001) . For example, acute application of BDNF induces synaptic potentiation at both developing neuromuscular junctions (NMJs) (Lohof et al., 1993) and synapses of the CNS (Kang and Schuman, 1995) . It is hypothesized that this function of BDNF plays an important role in strengthening synapses during development and in synaptic modification during learning and memory in the mature CNS (Poo, 2001 ; Kuipers and Bramham, 2006) . The molecular mechanisms underlying BDNF-induced synaptic potentiation are not well understood.
Tropomyosin-related kinase B (TrkB) is a high-affinity BDNF receptor and mediates most of its intracellular signaling cascades, whereas the p75 neurotrophin receptor (p75NTR) is a lowaffinity receptor that binds several neurotrophins (Chao and Hempstead, 1995) . It has been well documented that blockade of TrkB function restricts BDNF-induced potentiation at the NMJ and at CNS synapses (Lohof et al., 1993; Kang and Schuman, 1995) . Recently, p75NTR has been shown to be present at both presynaptic and postsynaptic sites in the adult mouse NMJ (Garcia et al., 2010) . However, a functional role of p75NTR in neurotrophin-induced synaptic enhancement at NMJ has not been clearly established. One major downstream mechanism underlying BDNF-induced plasticity is Ca 2ϩ signaling (Lohof et al., 1993; Kang and Schuman, 1995) . The molecular mechanism that mediates Ca 2ϩ influx in neurotrophin-induced plasticity remains elusive.
Canonical transient receptor potential channels (TRPCs) are Ca 2ϩ -permeable membrane channels (Clapham, 2003) . In cultured primary neurons, BDNF application leads to the activation of TRPC3 channels through TrkB signaling, accounting for I BDNF , a slow inward current (Li et al., 1999) . Furthermore, activation of TRPC channels is critical for BDNF-dependent cell survival (Jia et al., 2007) , axonal guidance (Li et al., 2005; Shim et al., 2005; Wang and Poo, 2005) , and dendritic outgrowth and spine formation (Amaral and Pozzo-Miller, 2007a,b) . Whether TRPC signaling is also involved in BDNFinduced synaptic potentiation remains unknown.
BDNF has been previously shown to induce Ca 2ϩ elevation in the presynaptic neuronal terminal at the developing Xenopus NMJ (Stoop and Poo, 1996; Kleiman et al., 2000; Shim et al., 2009) . Using both genetic and pharmacological approaches, here we show that XTRPC1 plays an important role in BDNF-induced synaptic potentiation at the developing Xenopus NMJ. Surprisingly, XTRPC1 function is required specifically in postsynaptic myocytes, but not in presynaptic neurons, for full BDNF-induced synaptic potentiation at the NMJ. Mechanistically, inhibition of XTRPC1 abolished the BDNFinduced Ca 2ϩ rise in myocytes. Furthermore, BDNF receptor p75NTR is required for BDNF-induced postsynaptic Ca 2ϩ responses in myocytes and full synaptic potentiation at the NMJ.
Materials and Methods
Microinjection of Xenopus embryos and culture of spinal neurons and myocytes. Injection of Xenopus embryos of either sexes and prepara- The addition of BDNF (50 ng/ml) is indicated by the arrow. Scale bars, 500 pA and 2 min. B, Fold change in the frequency of spontaneous PSCs. Value represent mean Ϯ SEM (control: n ϭ 13; SKF96365 treatment: n ϭ 14); *p Ͻ 0.05 (unpaired two-tailed Student's t test with Welch's correction). C, Cumulative distribution plots for the amplitude, 10 -90% rise time and decay time, and interevent intervals (p Ͻ 0.01; Kolmogorov-Smirnov Test) of spontaneous PSCs under different conditions. tion of dissociated spinal cultures were carried out as described previously Shim et al., 2005 Shim et al., , 2009 . Briefly, Xenopus eggs were collected and fertilized in vitro. After removal of the external jelly coat with 5% cysteine solution, embryos were injected at the one-or two-cell stage with ϳ10 ng of specific morpholino along with a fluorescent tracer, fluorescein isothiocyanate or rhodamine dextran. The control and XTRPC1 morpholino have been previously characterized for their specificity and efficacy in knocking down the endogenous Xenopus XTRPC1 protein with immunocytochemistry, Western blot analysis, and functional rescue experiments with the expression of the wild-type XTRPC1 gene (Shim et al., 2005) . The morpholino against Xenopus TrkB has also been characterized previously (Du and Poo, 2004) . The morpholino against Xenopus p75NTR was designed with the following targeting sequence: GGGTTTC-CATGCTGATCCTAGAAAG (Gene Tools). Embryonic spinal tissue was dissected from stage 22-24 embryos, dissociated using Ca 2ϩ -free solution and trituration, and then plated onto glass coverslips for electrophysiological recordings or imaging plates for Ca 2ϩ imaging. Cultures were incubated at room temperature for at least 14 h before use.
In situ hybridization of Xenopus embryos and immunostaining of spinal cultures. Wholemount in situ hybridization using the digoxigenin-UTP-labeled antisense RNA was performed as described previously (Harland, 1991; Shim et al., 2009 ). The C-terminal region of XTRPC1 was used for the specific antisense probe. The labeled probe was detected with alkaline phosphatase (AP)-conjugated anti-DIG antibody (Fab fragments) and visualized with the BM Purple AP substrate (Roche Applied Science). Immunocytochemistry of XTRPC1 of Xenopus neuron-myocyte cocultures was performed as described previously (Shim et al., 2005) . The primary antibody against XTRPC1 (Bobanovic et al., 1999; Shim et al., 2005 ) was used at 1:100 dilution, and the secondary antibody was used at 1:250 dilution.
Electrophysiological recordings. Spontaneous synaptic currents were recorded in myocytes by perforated patch (amphotericin, 240 g/ml) or by whole-cell patch clamp as described previously Ge et al., 2006) . Micropipettes (World Instruments) with 2.5-5 M⍀ resistance were filled with the following intracellular solution (in mM): 150 KCl, 2.9 NaCl, 1 MgCl 2 , and 10 HEPES, pH 7.2. Extracellular solution has the following composition (in mM): 140 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , and 10 HEPES, pH 7.4. Myocytes were voltage clamped at Ϫ70 mV. Data were collected using an Axopatch 200B amplifier and acquired using Digidata 1322A (Molecular Devices). The data were filtered by a lowpass Bessel filter at a frequency of 2 kHz and stored at 10 kHz. Baseline spontaneous excitatory postsynaptic currents (PSCs) were recorded for 5 min and for an additional 25 min period after the addition of 50 ng/ml BDNF (Peprotech; final bath concentration). There was a significant range of basal level synaptic transmission in this preparation of developing NMJ, and only recordings with baseline frequencies greater than two PSCs per minute were included for analysis . In this preparation, treatment of TTX does not affect the frequency and the amplitude of synaptic transmission . The characteristics of amplitude, 10 -90% rise time, decay time, and interevent intervals were analyzed under all experimental conditions. A Kolmogorov-Smirnov Test was used for cumulative distribution probabilities.
For the Ca 2ϩ chelator experiment, 5 mM EGTA or 5 mM BAPTA was included in the intracellular solution and whole-cell patch was used as described previously (Wan and Poo, 1999) . For experiments using NGFR5 p75NTR function-blocking antibodies, 5 g/ml NGFR5 (NeoMarkers) or control mouse IgG antibodies (MP Biomedicals) were added at least 30 min before the addition of BDNF. For most experiments, an unpaired Student's t test was used for statistics. Nonparametric ANOVA, Kruskal-Wallis ANOVA, and Dunn's post-test were also used, as noted in figure legends.
Calcium imaging. Ca 2ϩ imaging analysis was carried out as described previously (Ming et al., , 2002 Shim et al., 2009) . Briefly, cultures were rinsed with extracellular recording solution to eliminate culture media. Fluo-4 AM (2 M, Invitrogen) was added to cultures and allowed to incubate for 30 min and rinsed with the extracellular recording solution before imaging. For most of the experiments, images of a single confocal optic section were captured every 15 s (LSM 510 confocal, Zeiss) with 488 nm argon laser for excitation and 500 -560 nm for detection. After 2 min of baseline recording, BDNF (50 ng/ml) was added and recorded for additional 20 min in the presence or absence of SKF96365 (20 M; Calbiochem), XTRPC1-Mo, p75NTR-Ab, or p75NTR-Mo. In one set of experiments, isolated muscle cells under voltage clamp were used for Ca 2ϩ imaging with an epifluorescent microscope. Only cells with a stable baseline of less than a 10% change in the fluorescence intensity during the 2 min baseline recording period were used for quantification. A circle covering the whole myocyte was used as the region of interest, and data were analyzed with background subtraction and then normalized to the average intensity for the first 2 min as described previously (Ming et al., , 2002 Shim et al., 2009 ). Data were binned into 30 s increments. Student's t test with Welch's correction was used for the statistic analysis.
Results

Requirement of XTRPC1 function for BDNF-induced full synaptic potentiation at NMJs
Whole-mount in situ hybridization showed that XTRPC1 was detected at the dorsal-anterior part of developing Xenopus embryos at stage 20, with a gradual increase in the expression in the brain, spinal cord, and somites during the period of active NMJ synapse formation (Fig. 1A) . To determine whether XTRPC1 is required for BDNF-induced synaptic potentiation, we used a previously characterized morpholino antisense oligonucleotide specifically against XTRPC1 (XTRPC1-Mo) to knockdown the expression of endogenous XTRPC1 protein (Shim et al., 2005) . Immunostaining using specific antibodies against XTRPC1 confirmed that XTRPC1 was expressed in both spinal neurons and myocytes cultured from control nontargeting morpholino (control-Mo) injected embryos (Shim et al., 2005) , whereas XTRPC1 expression level was significantly lower in both neurons and myocytes from embryos injected with XTRPC1-Mo (Fig. 1B) . Consistent with previous findings (Lohof et al., 1993) , acute application of BDNF (50 ng/ml; final bath concentration) induced about fivefold increase in the frequency of spontaneous PSCs when recorded from myocytes at controlMo-injected Xenopus NMJs ( Fig. 1D,E ; interevent interval: 6.0 Ϯ 1.7 s before BDNF and 1.3 Ϯ 0.3 s after BDNF, n ϭ 10). The BDNF effect was significantly reduced when recording from NMJs derived from XTRPC1-Mo-injected embryos, with both the myocyte and neuron containing XTRPC1-Mo (p ϭ 0.04; Fig. 1C -F; interevent interval: 3.6 Ϯ 0.9 s before BDNF and 2.2 Ϯ 0.7 s after BDNF, n ϭ 16). There was no significant change in the mean amplitude of spontaneous PSCs in response to BDNF under control or knockdown conditions ( Fig. 1F ; control-Mo: 376.4 Ϯ 87.6 pA before BDNF and 442.0 Ϯ 85.0 pA after BDNF; p ϭ 0.43; XTRPC1-Mo: 332.7 Ϯ 55.7 pA before BDNF and 410.2 Ϯ 78.8 pA; p ϭ 0.61). Other characteristics of spontaneous PSCs, including 10 -90% rise time and decay time, were largely unaffected (Fig. 1F) . These results suggest a specific requirement of XTRPC1 channel function in the BDNF-induced increase in the frequency of spontaneous PSCs at the developing NMJ in culture.
To complement genetic manipulations, we used a pharmacological approach to acutely block TRPC function with SKF96365, a drug with limited specificity that has been used to block TRPC channels (20 M) (Shim et al., 2005; Wang and Poo, 2005) . Similar to XTRPC1-Mo, this treatment significantly attenuated BDNF-induced potentiation (p ϭ 0.03; Fig. 2 ; interevent interval: 5.7 Ϯ 1.3 s before BDNF and 3.0 Ϯ 0.6 s after BDNF, n ϭ 14).Together, these results suggest that XTPRC channels are required for BDNF-induced full synaptic potentiation at the NMJ in culture.
Postsynaptic, but not presynaptic, requirement of XTRPC1 function for BDNF-induced synaptic potentiation at NMJs BDNF-induced potentiation at the Xenopus NMJ is generally believed to be a purely presynaptic phenomenon (Schinder and Poo, 2000) based largely on the observation that BDNF treatment increases only the frequency of spontaneous PSC events, but not the amplitude (Lohof et al., 1993) (Fig. 1) . To examine whether XTRPC1 is required presynaptically in BDNF-induced synaptic potentiation of the NMJ, we used a coculture system with cells from both XTRPC1-Mo-injected embryos and control-noninjected embryos. Surprisingly, recordings from synaptic pairs in which a XTRPC1-Mo-containing neuron synapsed onto a wild-type myocyte showed normal BDNFinduced potentiation of the spontaneous PSC frequency, as com- pared to control-Mo neuron/wild-type myocyte pairs (p ϭ 0.85; Fig. 3 ; control-Mo interevent interval: 5.0 Ϯ 0.8 s before BDNF and 1.3 Ϯ 0.4 s after BDNF, n ϭ 11; XTRPC1-Mo interevent interval: 5.6 Ϯ 1.8 s before BDNF and 0.9 Ϯ 0.2 s after BDNF, n ϭ 12). Because XTRPC1 knockdown simultaneously in neurons and myocytes significantly reduced the BDNF-induced potentiation (Fig. 1) , these results suggested that XTRPC1 function is required postsynaptically.
To directly determine whether postsynaptic XTRPC1 function is required for BDNF-induced potentiation at the NMJ, we recorded from neuron-myocyte pairs in which a wild-type neuron synapsed onto a XTRPC1-Mo-containing myocyte (Fig. 4 A) . Indeed, the BDNF-induced increase in spontaneous PSC frequency was significantly attenuated in comparison with wildtype neuron/control-Mo myocyte pairs (p ϭ 0.03; Fig. 4 B-C; control-Mo interevent interval: 10.1 Ϯ 2.4 s before BDNF and 2.3 Ϯ 0.7 s after BDNF, n ϭ 14; XTRPC1-Mo interevent interval: 5.6 Ϯ 1.4 s before BDNF and 3.2 Ϯ 1.5 s after BDNF, n ϭ 17), whereas other characteristics of spontaneous PSCs were not affected (p Ͼ 0.05 among all groups; Fig. 4D ). Together, these results indicate a postsynaptic requirement of XTRPC1 function for synaptic potentiation of the NMJs in response to BDNF.
Requirement of XTRPC1-mediated Ca 2؉ elevation in myocytes for BDNF-induced potentiation
We have previously shown that XTRPC1 mediates the Ca 2ϩ influx into growth cones of developing Xenopus spinal neurons in response to BDNF (Shim et al., 2005 (Shim et al., , 2009 ). To confirm that Ca 2ϩ -permeable XTRPC1 channels are also activated postsynaptically in myocytes in response to BDNF, we performed Ca 2ϩ imaging analysis of neuron-myocyte pairs using the Ca 2ϩ indicator dye Fluo-4 AM. Myocytes loaded with Fluo-4 (2 M) exhibited a significant increase in the fluorescence intensity upon acute application of BDNF (50 ng/ml; p ϭ 0.01; Fig. 5 A, B) . This BDNF-induced Ca 2ϩ rise in myocytes was abolished when SKF96365 (20 M) was coadministered ( Fig. 5A and 5B), consistent with a role of XTRPC1 in the BDNF-induced Ca 2ϩ rise. Similar blockade of this Ca 2ϩ rise was observed in isolated myocytes with treatment of SKF96365 or in XTRPC1-Mo myocytes, but not in isolated wild-type myocytes under voltage clamp (Fig. 5C ).
To directly determine whether Ca 2ϩ elevation is required postsynaptically at the NMJ for BDNF-induced synaptic potentiation, we loaded EGTA (5 mM), a Ca 2ϩ chelator, into myocytes through the whole-cell recording pipette. Buffering Ca 2ϩ rise in the myocytes with EGTA significantly reduced BDNF-induced potentiation of spontaneous PSC frequency (p ϭ 0.02; Fig. 6 ; control interevent interval: 6.1 Ϯ 1.4 s before BDNF and 0.9 Ϯ 0.2 s after BDNF, n ϭ 14; EGTA interevent interval: 6.4 Ϯ 1.9 s before BDNF and 2.7 Ϯ 0.8 s after BDNF, n ϭ 17). Application of a faster Ca 2ϩ chelator, BAPTA (5 mM), in myocytes also attenuated BDNF-induced potentiation of spontaneous PSC frequency (p ϭ 0.03; Fig. 6 ; interevent interval: 7.7 Ϯ 2.2 s before BDNF and 12.9 Ϯ 11.6 s after BDNF, n ϭ 15). These results support the notion that BDNF-induced full synaptic potentiation requires postsynaptic Ca 2ϩ elevation through XTRPC1 in myocytes.
Presynaptic requirement of TrkB for BDNF-induced potentiation of NMJs
The TrkB receptor has long been known to be required for BDNF-induced synaptic potentiation (Lohof et al., 1993; Kang and Schuman, 1995) , and TRPC channels can be activated by TrkB signaling (Li et al., 1999) . Knocking down of XTrkB simultaneously in neurons and myocytes using a previously characterized morpholino specifically against Xenopus TrkB (XTrkB-Mo) (Du and Poo, 2004) abolished synaptic potentiation in response to BDNF (p ϭ 0.0003; Fig. 7A ,C; control interevent interval: 6.1 Ϯ 1.4 s before BDNF and 0.9 Ϯ 0.2 s after BDNF, n ϭ 10; XTrkB-Mo interevent interval: 8.2 Ϯ 2.2 s before BDNF and 5.0 Ϯ 1.5 s after BDNF, n ϭ 7). When we recorded from wild-type neuron/XTrkB-Mo myocyte pairs, BDNF-induced potentiation of spontaneous PSC frequency was maintained ( Fig. 7A ,C; interevent interval: 14.1 Ϯ 1.9 s before BDNF and 3.6 Ϯ 1.8 s after BDNF, n ϭ 12), suggesting that XTrkB is dispensable postsynaptically in the myocytes for BDNFinduced synaptic potentiation. This is in contrast to recordings from synaptic pairs with presynaptic XTrkB knockdown, where Values represent mean Ϯ SEM (n ϭ 7 for the control group; n ϭ 8 for the SKF96365 treatment); *p Ͻ 0.05 (unpaired two-tailed Student's t test with Welch's correction). C, Summary of peak ⌬F/F 0 values of Ca 2ϩ signal in myocytes under different conditions. Values represent mean Ϯ SEM (n ϭ 7 for the control group; n ϭ 8 for the SKF96365 treatment; n ϭ 8 for the SKF96365 treatment in isolated myocytes; n ϭ 11 for XTRPC1-Mo myocytes; n ϭ 5 for control and n ϭ 4 for XTRPC1-Mo myocytes under voltage clamp); **p Ͻ 0.01 (unpaired two-tailed Student's t test with Welch's correction).
BDNF-induced potentiation was essentially abolished (p ϭ 0.0003; Fig. 7 A, C; interevent interval: 7.0 Ϯ 2.2 s before BDNF and 5.7 Ϯ 1.8 s after BDNF, n ϭ 9). Therefore, synaptic potentiation in response to BDNF requires coordinated presynaptic and postsynaptic responses, with the presynaptic response mediated by TrkB receptor signaling.
Requirement of p75NTR for BDNF-induced potentiation and postsynaptic Ca
2؉ responses Activation of downstream signaling pathways through BDNFp75NTR modulates cell survival, neurite outgrowth, and synaptic plasticity (Underwood and Coulson, 2008) . Given the lack of involvement of TrkB in myocytes, we next examined whether p75NTR in myocytes is involved in BDNF-induced synaptic potentiation. Knocking down of p75NTR in myocytes using a morpholino specifically against Xenopus p75NTR (p75NTR-Mo) significantly attenuated BDNF-induced synaptic potentiation of the frequency of spontaneous PSCs at the NMJ (p ϭ 0.01; Fig. 7 B, D ; control interevent interval: 6.1 Ϯ 1.4 s before BDNF and 0.9 Ϯ 0.2 s after BDNF, n ϭ 10; p75NTR-Mo interevent interval: 8.5 Ϯ 1.9 s before BDNF and 3.6 Ϯ 1.0 s after BDNF, n ϭ 16). A similar effect was observed after preincubating cultures with NGFR5 (5 g/ml; p ϭ 0.01; Fig. 7B, D; interevent interval: 7.1 Ϯ 1.5 s before BDNF and 3.3 Ϯ 1.0 s after BDNF; n ϭ 9), a function-blocking antibody that has been previously shown to suppress p75NTR function in Xenopus spinal cultures ). In contrast, preincubation with a control IgG antibody (5 g/ml) did not affect BDNF-induced synaptic potentiation of the frequency of spontaneous PSCs at the NMJ (p ϭ 0.44; Fig. 7 B, D; interevent interval: 9.5 Ϯ 1.7 s before BDNF and 2.0 Ϯ 0.6 s after BDNF, n ϭ 16). To further assess the potential contribution of BDNFp75NTR signaling to the XTRPC1-mediated Ca 2ϩ elevation in myocytes, we quantified the BDNF-induced Ca 2ϩ response with inhibition of p75NTR. NGFR5 application essentially blocked BDNF-induced Ca 2ϩ elevation in myocytes, in comparison to pretreatment with the control antibody (p ϭ 0.02; Fig. 7E,F ) . Similarly, p75NTR-Mo myocytes did not exhibit any significant BDNF-induced Ca 2ϩ rise (Fig. 7F ) . Together, these results are consistent with the notion that the p75NTR receptor function is required in postsynaptic myocytes for BDNFinduced Ca 2ϩ elevation in myocytes and for BDNF-induced synaptic potentiation at the developing Xenopus NMJ.
Discussion
It has been well documented that BDNF plays essential roles in modulating various forms of synaptic plasticity and in shaping neuronal networks (Schinder and Poo, 2000; Reichardt, 2006; Martinowich et al., 2007) . Dysregulation of BDNF signaling and functional BDNF polymorphisms have also been implicated in multiple neurodegenerative diseases, schizophrenia, and various mood disorders in humans (Hashimoto, 2010; Yoshii and Constantine-Paton, 2010; Buckley et al., 2011) . Elucidating the molecular and cellular mechanisms underlying BDNFdependent modulation of synaptic transmission remains critically important for understanding the basic biology and pathophysiology of relevant neurological diseases. Using the developing Xenopus NMJ as a model system, our study identified a critical role of TRPC1 in BDNFdependent regulation of synaptic efficacy and revealed a surprising requirement of TRPC1-mediated postsynaptic Ca 2ϩ signaling. Our results suggest a novel model in which full synaptic potentiation in response to BDNF at the developing NMJ requires coordinated presynaptic and postsynaptic responses, involving both presynaptic TrkB receptor signaling and postsynaptic p75NTR/TRPC signaling.
The NMJ is the synapse where BDNF was first reported to positively modulate synaptic transmission (Lohof et al., 1993) , and this system has remained a model synapse for understanding molecular mechanisms underlying neurotrophin-induced synaptic plasticity because of its simplicity and accessibility. Importantly, many mechanisms identified at NMJs have been shown to be conserved at mammalian CNS synapses (Kang and Schuman, 1995) . For example, Ca 2ϩ influx was first shown to be an important signal transducer in BDNF-induced synaptic potentiation at NMJs (Stoop and Poo, 1996) , and a similar role in CNS synapses has since been well documented (Li et al., 1998; Zhang and Poo, 2002; Minichiello, 2009) . Furthermore, components downstream of BDNF signaling are also largely conserved between NMJ and CNS synapses, including phospholipase C and MAPK activation cascade (Ohira and Hayashi, 2009; Numakawa et al., 2010) . The molecular entities that mediate Ca 2ϩ mobilization remain largely unknown. In this study, using genetic and pharmacological manipulations, we showed that Ca 2ϩ -permeable TRPC channels are required for BDNF-induced Ca 2ϩ entry into postsynaptic myocytes and synaptic potentiation at the developing NMJs. Our study adds TRPC1 as a new player in a growing list of postsynaptic signaling molecules at the NMJs (Lai and Ip, 2003) . Together with previous findings (Li et al., 2005 ; Shim et al., 2005; Wang and Poo, 2005; Amaral and Pozzo-Miller, 2007a,b) , these results also demonstrate conserved roles of TRPC channels for a spectrum of BDNF functions within the nervous system, including neuronal survival, axon guidance, dendritic spine formation, and synaptic plasticity.
It is generally believed that BDNFinduced potentiation at the NMJ is a purely presynaptic event based primarily on the observation that BDNF enhances the frequency, but not the amplitude, of spontaneous PSCs (Schinder and Poo, 2000) . Ca 2ϩ imaging confirmed a presynaptic requirement of Ca 2ϩ elevation both in the NMJ and in cultured hippocampal neurons in response to BDNF, and removal of extracellular Ca 2ϩ also inhibits the synaptic potentiation (Stoop and Poo, 1996; Li et al., 1998; Kleiman et al., 2000) . Notably, removal of extracellular Ca 2ϩ affects both presynaptic and postsynaptic sites, and most of the previous Ca 2ϩ imaging studies focused only on presynaptic neurons. We found that BDNF stimulation led to small but significant Ca 2ϩ elevation within myocytes that exhibited slow kinetics and a dependence on TRPC1 channel activity. Consistently, application of Ca 2ϩ chelators specifically in myocytes attenuated BDNF-induced potentiation at the NMJ. Interestingly, chelating Ca 2ϩ in myocytes has been shown to prevent synaptic potentiation induced by bursting activity of the innervating neurons at the developing Xenopus NMJs (Wan and Poo, 1999) . In cultured hippocampal neurons, TRPC3 channels are required for BDNF modulation of dendritic spine density (Amaral and Pozzo-Miller, 2007a) , and presynaptic release of BDNF from mossy fiber activates TRPC3 in postsynaptic CA3 pyramidal neurons (Li et al., 2010) . BDNF also appears to regulate postsynaptic AMPAR insertion in cortical neurons through TRPCs (Nakata and Nakamura, 2007) . Together, these studies support the notion that synaptic modulation by BDNF requires presynaptic and postsynaptic Ca 2ϩ signaling in both PNS and CNS. The mechanisms by which a postsynaptic Ca 2ϩ elevation results in an increase in the frequency, but not the amplitude, of spontaneous release remains to be determined, likely involving retrograde signals (Murphey and Davis, 1994; Fitzsimonds and Poo, 1998; Salinas, 2005; Marqués and Zhang, 2006; Kano et al., 2009 ).
TrkB and p75NTR, both BDNF receptors, are capable of activating TRPC currents individually (Li et al., 1999; Ló pezDomínguez et al., 2006; Amaral and Pozzo-Miller, 2007a) . Consistent with previous studies, we confirmed a presynaptic requirement of TrkB receptors for BDNF-induced synaptic potentiation. We further provided evidence that p75NTR is important for BDNF-induced postsynaptic Ca 2ϩ elevation and synaptic potentiation at the developing NMJ. A recent study demonstrated that inhibition of either the TrkB receptor or p75NTR could inhibit synaptic potentiation at the rodent NMJ, although it was not determined whether the receptors were required presynaptically or postsynaptically (Garcia et al., 2010) . In addition, a postsynaptic role of p75NTR has been implicated in regulation of dendritic spine density and dendritic complexity (Zagrebelsky et al., 2005) . P75NTR has been shown to be linked to several signaling pathways, including Jun kinase (CasacciaBonnefil et al., 1996) , NF-B (Yoon et al., 1998), PTEN (Song et al., 2010) , and Rho-ROCK pathways (Yamashita et al., 1999) , for its regulation of cell survival and cytoskeletal proteins. Our study pro- Figure 7 . p75NTR function is required for BDNF-induced synaptic potentiation and postsynaptic Ca 2ϩ elevation. A, TrkB function is required presynaptically, but not postsynaptically, for BDNF-induced potentiation. Shown is a summary of fold changes in spontaneous PSCs frequency with pairs of NMJs containing morpholino for XTRKB (XTRKB-Mo) in neurons and/or myocytes. The addition of BDNF (50 ng/ml; final bath concentration) is indicated by the arrow. Values represent mean Ϯ SEM; **p Ͻ 0.01; *p Ͻ 0.05 (Kruskal-Wallis ANOVA test and a Dunn's post-test). B, p75NTR is required postsynaptically for BDNF-induced synaptic potentiation. Shown is a summary of fold changes in spontaneous PSCs frequency after BDNF induction (50 ng/ml) in the presence of NGFR5 or the control antibody (5 g/ml) or from p75NTR-Mo myocytes. Values represent mean Ϯ SEM; *p Ͻ 0.05 (unpaired two-tailed Student's t test with Welch's correction). C, D, Cumulative distribution plots for the amplitude, 10 -90% rise time, decay time, and interevent intervals (p Ͻ 0.01; Kolmogorov-Smirnov Test) of spontaneous PSCs under different conditions. E, F, p75NTR function is required for BDNF-induced Ca 2ϩ response in myocytes. Shown in E are sample confocal images of Ca 2ϩ responses of the myocytes in the presence of a control antibody (5 g/ml; top) or NGFR5 (5 g/ml; bottom). Scale bar, 10 m. Shown in F is a summary of normalized F/F 0 values in the myocytes. Values represent mean Ϯ SEM (n ϭ 9 for NGFR5; n ϭ 7 for control IgG; n ϭ 6 for p75NTR-Mo); *p Ͻ 0.05 (unpaired two-tailed Student's t test with Welch's correction).
vides a link between p75NTR and TRPC activation for Ca 2ϩ signal regulation. The detailed molecular mechanism underlying p75NTR activation of TRPC1 remains to be determined.
In summary, our study supports a model in which the coordinated activation of presynaptic TrkB and postsynaptic p75NTR is required for full potentiation of NMJ synapses in response to BDNF. While inhibition of TrkB specifically in neurons completely abolished the potentiation, blocking TRPC channels and Ca 2ϩ signaling in postsynaptic myocytes only blocked potentiation at the late phase, but not the initial phase, suggesting that TrkB receptors are activated first and are necessary for BDNFinduced potentiation before the contribution of postsynaptic p75NTR and TRPC1. Given the broad action of BDNF in the nervous system, our findings on the molecular mechanism mediating BDNF-induced potentiation at the NMJ may have significant implications for understanding the establishment and plasticity of synapses throughout the nervous system and how dysregulation of this pathway may contribute to neurodegenerative and cognitive disorders.
